. Evidence is also accumulating that nitric oxide contributes to the regulation of the secretion of renin and vasopressin, hormones that play key roles in the control of sodium and water balance. The purpose of this review is to summarize recent progress concerning the role of nitric oxide in the secretion of these two hormones.
THE L-ARGININE/NITRIC OXIDE PATHWAY
The L-arginine/nitric oxide pathway is shown in Fig. 1 . Nitric oxide is formed from the terminal guanidino group of L-arginine by the enzyme nitric oxide synthase (8, 63, 77) . Three distinct isoforms of nitric oxide synthase have been identified and their cDNA has been cloned and sequenced (38, 63, 65, 78) . In humans, the isoforms are encoded by three different genes each located on differentchromosomes. Eachisoformcontainshemeat its activesite andall requirethe cofactors NADPH, tetrahydrobiopterin, flavinadeninedinucleotide, andflavinmononucleotide. Type I nitric oxide synthase(alsoreferredto as bNOSand nNOS)was originally identifiedin neuronsand is distributedwidelyin the brain and autonomicnervoussystem. It is expressed constitutivelyandis activatedby calciumboundto calmodulin. TypeII nitric oxidesynthase (iNOS)is expressed in macrophages, smoothmuscle, and the liver after inductionby bacterial lipopolysaccharide or cytokines. Expression of this isoformrequiresprotein synthesis, but enzyme activityis not dependent oncalcium. TypeIII nitric oxide synthase (eNOS) wasoriginallyidentifiedin endothelial cellsbut it hasalsobeen foundin kidneyepithelial cells. LikeTypeI nitric oxidesynthase, it is expressed constitutivelyand is activatedby calcium/calmodulin. Type III nitric oxide synthase is responsible forendothelium-dependent relaxation ofvascular smooth muscle.
Nitric oxideis quite diffusible, but is rapidlyinactivatedwith a half-life of approximately 5 s and is thought to function primarily in a paracrineor autocrinefashion. A majortargetfornitric oxideis soluble guanylyl cyclase (34). Nitric oxidebindsto iron in the hemeat the activesite of guanylylcyclase, alteringthe conformationof the enzymeandtherebyincreasingits activity. Stimulationof guanylylcyclaseactivity by nitric oxide in turn results in increased formationofcyclicguanosine 3',5'-monophosphate (cyclicGMP)whose targetsincludephosphodiesterases, ion channels, anda cyclicGMP-dependent proteinkinase that mediates smoothmuscle relaxation.
Nitric Oxide Synthase and Guanylyl Cyclase in the Kidney
The presence of Type I nitric oxide synthase in the kidney has been demonstrated by immunocytochemistry and NADPH histochemistry (69, 79, 119, 129 
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Macula Densa
The macula densa serves as an NaC1 sensor which signals an increase in renin secretion when the amount of NaC1 delivered to the distal nephron decreases (28, 46, 62, 124) . This mechanism involves an Na÷-K+-2C1 cotransporter located in the luminal membrane of the macula densa cells (9, 68, 106 
Signal Transduction
The signal transduction mechanisms involved in the control of renin secretion have been studied extensively (20, 22, 29, 55, 66, 114 provided support for such a pressure-dependent mechanism. They showed that the suppression of renin secretion elicited by the nitric oxide synthase inhibitor N'-nitro-a-arginine methyl ester (L-NAME, Our finding that milrinone prevents the suppression of renin secretion by L-NAME (92) provides support for such a mechanism. The possible role of PDE III is discussed in more detail below in the section on nitric oxide and beta adrenoceptor control of renin secretion. Changes in cyclic AMP metabolism may be involved. In other circumstances, for example, long-termtreatment,inhibition of nitric oxidesynthesisincreases renin secretion. Further studyof thesechanges in renin secretion andof the mechanisms underlying themis needed.
Pressure-Dependent Renin Secretion
The renin secretory response to a decrease in renal perfusion pressure is thought to be mediated by a reduction in calcium concentration in the juxtaglomerular cells (22, 66 7 . Phenylephrine produced the same increase in blood pressure as L-NAME, but did not significantly alter the renin or heart rate responses to isoproterenol.
Thus, it is unlikely that the pressor effect of L-NAME was responsible for the suppression of the renin response to isoproterenol. Fig. 8 , a similar mechanism could explain the suppression of the renin response to isoproterenol.
Central to the scheme proposed in Fig. 8 is the enzyme PDE III. This enzyme Hypothetical mechanism by which inhibition of nitric oxide synthesis with L-NAME could suppress the renin secretory response to beta adrenoceptor stimulation with isoproterenol (ISO). According to this hypothesis, L-NAME decreases nitric oxide synthesis in the vicinity of the juxtaglomerular cells. As a result, soluble guanylyl activity and cyclic GMP concentration in the juxtaglomerular cells decrease. The inhibition of the cyclic GMP-inhibitable phosphodiesterase (PDE III) is removed, and hydrolysis of cyclic AMP increases. Consequently, both basal renin secretion and the renin response to ISO decrease. Broken arrow indicates inhibition. injected at 0 min. Note that the maximum renin response to administration of L-NAME occurs within the first 15 min (see (9D and Fig. 3 
